The present experiment was performed to identify endothelium-derived contracting factor produced by acetylcholine stimulation in the aorta of spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats. The rings of the thoracic aorta were obtained from age-matched SHR and WKY rats, and changes in isometric tension were recorded. The relaxant responses to acetylcholine in the aortic rings from SHR were significantly weaker than those from WKY rats. The relaxant responses to acetylcholine were significantly enhanced by pretreatment with a cyclooxygenase inhibitor (indomethacin) or thromboxane A 2 / prostaglandin H 2 receptor antagonist (ONO-3708) in aortic rings from both SHR and WKY rats. A thromboxane A 2 synthetase inhibitor (OKY-046) did not affect the acetylcholineinduced relaxation in the aortic rings from SHR or WKY rats. In the organ bath solution, after acetylcholine stimulation, prostaglandin E 2 and 6-keto-prostaglandin F la concentrations increased but not prostaglandin F 2a and thromboxane B 2 concentrations. Exogenous prostaglandin H 2 , a stable analogue of thromboxane A 2 , and prostaglandin F 2a induced contractions of the SHR rings at a lower concentration than prostaglandin E 2 , prostaglandin D 2 , and prostaglandin I 2 . These contractile responses to various prostaglandins were markedly inhibited by pretreatment with ONO-3708. A prostacyclin synthetase inhibitor did not affect the relaxant responses to acetylcholine in the SHR rings. These results show that endotheliumderived contracting factor is produced and released by acetylcholine stimulation not only in the aorta of SHR but also in those of WKY rats and suggest that prostaglandin H 2 , a precursor of the released prostaglandins, is a strong candidate for endothelium-derived contracting factor produced by acetylcholine stimulation. (Hypertension 1990;15:475-481) A ll blood vessels are lined by the endothelium, and the important role of an organic or functional abnormality of endothelial cells in the pathogenesis and pathophysiology of various diseases has attracted attention.
Recently, endothelin was identified as an EDCF. This substance is the most potent mammalian vasoconstrictor peptide and has characteristic constricting effects. The endothelin-induced contraction is resistant to cyclooxygenase inhibitors, lipoxygenase inhibitors, and a-adrenergic, histaminergic, and serotonergic antagonists. 15 In the aorta of spontaneously hypertensive rats (SHR), acetylcholine causes the simultaneous release of EDRF and an EDCF that differs from endothelin, which is a peptide, and is considered to be a cyclooxygenase product. 16 However, the details remain obscure. We performed the present study to identify the EDCF, which is produced by acetylcholine stimulation in the SHR aorta.
Methods
The thoracic aorta from male SHR and normotensive Wistar-Kyoto (WKY) rats matched for age (30-32 weeks) and body weight (330-400 g) was used. Blood pressure measured by the tail-cuff method in the unanesthetized state was 191.9±3.4 mm Hg in SHR («=8) and 140.6±1. 5 
mm Hg in WKY rats (n=8).
The rats were decapitated, and the thorax was opened. The thoracic aorta was immediately removed and placed in cold Krebs-Henseleit solution with the following composition (mM): NaCl 118, KC1 4.7, CaCl 2 2.55, MgSC-41. 18 , KH 2 PO 4 1.18, NaHCO 3 24 .88, glucose 11.1, and Ca-2Na EDTA 0.026. The fat and connective tissues on the vascular surface were removed, and the vessel was cut into rings (5 mm in length) with scissors. After two stainless steel wires were inserted into the vascular lumen, the rings were suspended in an organ chamber, which contained 30 ml buffer bubbled with a mixture of 95% O 2 and 5% CO 2 and maintained at 37° C, and were connected to a force-transducer (model TB-612T, Nihonkohden, Tokyo, Japan). During this period, care was taken not to apply unnecessary tension to the aortic rings or damage their luminal surface. The rings were allowed to equilibrate for 90 minutes, during which buffer was replaced at 30-minute intervals. The resting tension was adjusted to 1.0 g. The intimal surface was removed by gentle rubbing with a swab inserted into the vascular lumen. Removal of the intima was confirmed by the absence of responses to 10~7 M acetylcholine.
Responses to Norepinephrine
Norepinephrine was cumulatively added to the bath solution for the aortic rings from SHR or WKY rats at concentrations of 10" 8 to 10~5 M, and changes in tension were evaluated. In the rings from SHR, the contraction induced by 10" 7 M norepinephrine was 77.2±3.2% (n=6) of the maximum contraction (10~6 M norepinephrine). In the rings from WKY rats, the contraction induced by 10~7 M norepinephrine was 75.7±2.0% («=6) of the maximum contraction (10~6 M norepinephrine). Because there was no significant difference between these values, the rings from both SHR and WKY rats were contracted with 10" 7 M norepinephrine.
Responses to Acetylcholine and Effects of Inhibitors and an Antagonist
The aortic rings with and without endothelium from SHR and WKY rats were contracted with 10" 7 M norepinephrine. After the contraction reached a plateau, acetylcholine was added at cumulative concentrations of 10~8 to 10" 5 M to relax the rings. Fifteen minutes before the induction of contractions by norepinephrine, indomethacin, 17 which is a cyclooxygenase inhibitor (10~5 M), OKY-046, 18 which is a TXA 2 synthetase inhibitor (10~5 M), and ONO-3708, 19 which is a TXA 2 /prostaglandin H 2 (PGH 2 ) receptor antagonist (10~6 M) were each added separately to the bath solution, and each effect on relaxant responses to acetylcholine was evaluated. The rates of relaxation were expressed as percentages to the contraction induced by 10" 7 M norepinephrine.
All the following experiments were done in the aortic rings from SHR alone.
Concentrations of Prostaglandins in the Bath Solution
In the SHR rings, changes in the concentrations of various prostaglandins (PGs) in the bath solution before and after addition of acetylcholine were evaluated. Immediately before the induction of contractions by norepinephrine, at the peak response to 10~7 M norepinephrine and at the peak response to 10~5 M acetylcholine after cumulative addition of 10" 8 to 10" 5 M acetylcholine, the organ bath solution (1 ml) was obtained, and the concentrations of PGE 2 , 6-keto-PGF la , and TXB 2 using a radioimmunoassay (RIA) kit prepared by New England Nuclear (Boston, Massachusetts) and PGF 2a using an RIA kit prepared by Clinical Assays (Cambridge, Massachusetts) were determined by the RIA method of Jaffe et al 20 
Effects of a Prostacyclin Synthetase Inhibitor
Tranylcypromine, 22 a prostacyclin synthetase inhibitor, was added to the bath solution at a concentration of 10" 4 M 15 minutes before the induction of contraction by norepinephrine, and its effects on relaxant responses to acetylcholine in the rings from the SHR were evaluated. 
Drugs
The following drugs from Sigma Chemical Co. (St. Louis, Missouri) were used: /-norepinephrine bitartrate, acetylcholine chloride, indomethacin, tranylcypromine, sodium nitroprusside, and PGI 2 . Ono Pharmaceutical Company (Osaka, Japan) provided the PGF 2a , PGE 2 , PGD 2 , PGH 2 , 9,ll-epithio-ll,12-methano-TXA 2 (STA 2 ), (E)-3[4-(l-imidazolylmethyl)phenyl]-2-propenoic acid hydrochloride monohydrate (OKY-046) (a TXA 2 synthetase inhibitor), and (9,ll),(ll,12)-dideoxa-9a,lla-dimethylmethanoll,12-methano-13,14-dihydro-13-aza-14-oxo-15-cyclopentyl-16,17,18,19,20-pentanor-15-epi-TXA 2 (ONO-3708) (a TXA 2 /PGH 2 antagonist). Indomethacin was dissolved in distilled water containing 3 x 10~2 M Na 2 CO 3 . PGI 2 , PGF^ PGE,, PGD 2 , PGH 2 , and STA 2 were dissolved in ethanol. The final ethanol concentration in the bath solution was 0.1% or less. The other drugs were dissolved in distilled water.
Vehicle did not affect the acetylcholine-induced relaxations or the resting tension. Results were expressed as mean±SEM. For statistical analysis, Student's / test for paired or unpaired observations and the Wilcoxon test were used. Values of p<0.05 were considered to be significant.
Results

Responses to Acetylcholine
In the aortic rings from both SHR and WKY rats, the maximum relaxation was observed with 10" 7 M acetylcholine. At higher concentrations, acetylcholine induced contractions ( Figure 1A , Figure 2 ). In the rings without endothelium from SHR and WKY rats, responses to acetylcholine were negligible (Figure IB, Figure 2 ). The acetylcholine-induced relaxation in rings from the SHR was significantly weaker than that in rings from the WKY rats at acetylcholine concentrations of 10~7 to 10~5 M (Figure 2 ).
Effects of Inhibitors and an Antagonist
In the rings from the SHR, relaxant responses were enhanced by pretreatment with indomethacin (10~5 M) at acetylcholine concentrations of 10" in the rings from the WKY rats relaxant responses were enhanced at acetylcholine concentrations of 10~6 to 10~5 M, resulting in relaxation similar in degree to that of rings from SHR and WKY rats ( Figure 6 ). The degree of the enhancement of relaxation was comparable with that after pretreatment with indomethacin. Indomethacin, OKY-046, and ONO-3708 did not significantly affect the contractions induced by 10~7 M norepinephrine in the rings from SHR and WKY rats.
ONO-3708 (1(T 6 M) did not significantly affect the relaxant responses to sodium nitroprusside in the rings from SHR and WKY rats (data not shown).
Concentrations of Prostaglandins in the Bath Solution
In rings from the SHR, the concentrations of PGE 2 and 6-keto-PGF, a increased about threefold to fourfold after acetylcholine stimulation. The concentration of PGE 2 in the bath solution after acetylcholine stimulation was about 10" 10 M, and that of 6-keto-PGF la was about 10" 9 M. The concentrations of PGF 2a and TXB 2 did not change significantly (Figure 7 ).
Responses to Exogenous Prostaglandins
In the SHR aortic rings with endothelium, PGF 2a , STA 2 , PGH 2 , PGE 2 , PGD 2 , and PGI 2 induced only contractions at the basal state. STA 2 , PGF 2a , and PGH 2 induced contractions at 10~7 M or more; on the other hand, PGE 2 and PGD 2 induced contractions only at a high concentration of 10" 6 M and PGI 2 at 10" 5 M (Figure 8 ). ONO-3708 at a concentration of 10~6 M inhibited all contractile responses to the various PGs (Figure 8 ). In the SHR aortic rings without endothelium at the basal state, results similar to those in the SHR aortic rings with endothelium were obtained (data not shown).
In the SHR aortic rings with and without endothelium, PGF 2a , STA 2 , PGH 2 , PGE 2 , and PGD 2 also induced only contractions at the precontracted state. Results similar to those at the basal state were obtained, although the percentage of contraction was reduced (data not shown).
Effects of a Prostacyclin Synthetase Inhibitor
The contractions in the rings from SHR induced by PGI 2 at high concentrations presented the possibility that PGI 2 is EDCF. Therefore, the effects of tranylcypromine (10~4 M) on relaxant responses to acetylcholine in rings from the SHR were evaluated. Because tranylcypromine reduced the norepinephrine-induced contractions, the rings were contracted with 10~6 M norepinephrine to obtain responses comparable with those in the control group. Tranylcypromine had no significant effect on acetylcholineinduced relaxation in rings from the SHR (Figure 9) . PGI 2 is known to have potent vasodilating effects. In the SHR aortic rings with and without endothelium at the basal state, contractions were induced with 10" 5 M PGI 2 , but there were no significant changes at 10~9 to 10" 6 M. At the precontracted state, negligible or only slight relaxations were observed at PGI 2 aorta of SHR than in those of WKY rats. 23 These weaker relaxations in the SHR aorta have been suggested to be due to EDCF produced and released by acetylcholine stimulation in the SHR aorta. 16 The present study confirmed significantly weaker relaxant responses to acetylcholine at concentrations of 10~7 to 10~5 M in the SHR aortic rings than in the WKY rat aortic rings. Indomethacin and ONO-3708 enhanced the relaxations at acetylcholine concentrations of 10" and released by acetylcholine stimulation in the endothelium. This substance (EDCF) produced and released simultaneously with EDRF seems to weaken acetylcholine-induced relaxations. EDCF has been considered to be present only in SHR. 16 However, our results suggest that EDCF is also produced and released by acetylcholine stimulation in the WKY rat aorta. Endothelium-dependent relaxations have been reduced in vascular smooth muscle of the rat with increasing age. 24 The existence of EDCF in WKY rats suggests that EDCF may participate in the reduced endothelium-dependent relaxations with increasing age. Therefore, age and blood pressure may promote endothelium-dependent contractions in the aorta of the rat. Whether the difference in response between the SHR and WKY rat aortic rings is caused by a difference in the amount of EDCF produced by acetylcholine stimulation or that in the sensitivity of the smooth muscle to EDCF remains to be clarified.
Reports have suggested a substance in the cyclooxygenase system 16 to be the EDCF produced and released, from the rat aorta. This was confirmed by the present study. To identify EDCF, the possibility of TXA 2 involvement was evaluated at first. This EDCF was not inhibited by OKY-046, a TXA 2 synthetase inhibitor, but was inhibited by ONO-3708, a TXA 2 /PGH 2 receptor antagonist. ONO-3708, which inhibits the actions of TXA 2 and PGH 2 , 19 also inhibited contractions induced by PGF 2aJ PGE 2 , PGD 2 , and PGI 2 . This result shows that ONO-3708 is not a selective antagonist to TXA 2 and PGH 2 . Consequently, EDCF seems to be a cyclooxygenase product or products other than TXA 2 as reported previously. 16 Next, the concentrations of various PGs in the organ bath solution were determined. After acetylcholine stimulation, the concentrations of PGE 2 and 6-keto-PGF la increased about threefold to fourfold. The concentration of PGE 2 in the bath solution after acetylcholine stimulation was about 10~1 0 M and that of 6-keto-PGF la (i.e., PGI 2 ) was about 10~9 M. Liischer et al 25 tion of 10" 6 M and PGI 2 at 10" 5 M. The concentrations of PGE 2 and PGI 2 measured in the bath solution were very low, and the concentrations that induced contractions were about 10 4 times higher. Although the degree of transfer of a substance produced in the tissue to the solution is not known, the local concentrations of the PGs released from the endothelium within the blood vessel wall would be much higher than those measured in the organ chamber. Tranylcypromine, a prostacyclin synthetase inhibitor of acetylcholine-induced relaxations, had no effect, which is consistent with the result of the previous report, 16 which suggests that PGI 2 is not increased in the tissue to the degree that induces vascular contractions. Therefore, there is only a slight possibility that PGI 2 or PGE 2 is EDCF. In addition, that there was no increase in the concentrations of PGF 2a and TXB 2 in the solution excludes the possibility that PGF 2a or TXA 2 is EDCF. These results suggest a cyclooxygenase product or products other than TXA 2 , PGE 2 , PGI 2) or PGF 2o as the EDCF produced and released by acetylcholine stimulation in the SHR and WKY rat aorta. PGI 2 is produced in endothelial cells and has potent vasodilating effects. When administered exogenously, it is known to induce biphasic responses in some types of blood vessels: relaxation is observed at low concentrations and contraction at high concentrations. 26 -30 After acetylcholine stimulation, the concentration of PGI 2 in the solution increased. The degree of the involvement of this increased PGI 2 in relaxations in the rat aorta was evaluated. The aortic rings at the basal state showed no changes in tension at PGI 2 concentrations of 10" 9 to 10~6 M. Contractions were induced at 10~5 M. The rings contracted with 10" 7 M norepinephrine showed neg-ligible change or only slight relaxation at PGI 2 concentrations of 10~9 to 10" 6 M. At 10" 5 M, contractions were induced. Therefore, PGI 2 increased by acetylcholine stimulation is not likely to be involved in not only contractions but also relaxations in the rat aorta.
In the present experiment, we could not identify EDCF produced by acetylcholine stimulation in the rat aorta but found that: 1) There is a very slight possibility that the final product in the cyclooxygenase system is an EDCF. 2) Exogenous PGH 2 induced contractions at 10" 7 M or more.
3) The contractions induced by PGH 2 were inhibited by ONO-3708. 4) The concentrations of PGI 2 and PGE 2 increased after acetylcholine stimulation in the organ bath solution. The concentration of PGI 2 in the bath solution after acetylcholine stimulation was about 10" 9 M and that of PGE 2 was about 1(T 10 M. 5) The volume of the aortic ring was about 1/10 3 to 1/10 4 of that of the organ bath solution. Taking the concentrations of PGs measured in the organ bath solution and a volume ratio of the vascular tissue to the organ bath solution into consideration, the concentration of PGH 2 , a precursor of the released PGs, would be at least 10" 6 M or more in the vascular tissue. Therefore, it seems that the concentration of PGH 2 produced in the tissue is sufficient to induce vascular contractions. These observations suggest that PGH 2 is a strong candidate for EDCF produced by acetylcholine stimulation in the rat aorta.
